GlassScriptPhysician profile
Katey Khune
NPI 1992394035
$1,952.52
in general payments reported to CMS, 2019-2025
20 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $143 · 2022: $430 · 2023: $613 · 2024: $462 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $541.98 | 2021-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $288.65 | 2021-2024 | Farxiga, Brilinta |
| Janssen Pharmaceuticals, INC | $262.22 | 2021-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $146.34 | 2021-2025 | |
| Boston Scientific Corporation | $114.47 | 2023-2025 | Eluvia, Cds - Other, Watchman Flx |
| Abiomed | $108.02 | 2024-2025 | Impella |
| Novo Nordisk INC | $86.05 | 2024-2025 | Wegovy, Ozempic |
| Stryker Corporation | $52.41 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Terumo Medical Corporation | $52.33 | 2022-2024 | Heartrail |
| Shockwave Medical, INC | $50.99 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Teleflex LLC | $35.76 | 2023 | Guideliner, Langston |
| E.R. Squibb & Sons, L.L.C. | $34.35 | 2024 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $33.41 | 2021-2022 | |
| Inari Medical, INC. | $31.87 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Octapharma USA, INC. | $24.28 | 2025 | Fibryga |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20.89 | 2025 | |
| Cardiva Medical, INC. | $20.56 | 2025 | Savvywire |
| Bayer Healthcare Pharmaceuticals INC. | $18.92 | 2023 | |
| Medtronic, INC. | $18.25 | 2025 | Symplicity G3 |
| Janssen Scientific Affairs, LLC | $10.77 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katey Khune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.